Clinical trial
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
NCT02857530 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
- Lead sponsor
- Tianjin Medical University General Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- July 31, 2020
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.